Clinical Trial Update: Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Uproleselan in combination with chemotherapy for Relapsed/Refractory acute myeloid leukemia in Chinese patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Uproleselan (uproleselan)

Snippet

Sponsor: Apollomics Inc. | Conditions: Relapsed/Refractory AML | Phase 3 | Status: TERMINATED